.

Make Better Decisions

  • Identify first generic entrants
  • Uncover prior art in expired and abandoned patents
  • Drug patents in 130+ countries

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Novartis
McKinsey
Accenture
McKesson
Argus Health
Baxter
Cerilliant
QuintilesIMS
Harvard Business School
Chinese Patent Office

Generated: December 12, 2017

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 012945

« Back to Dashboard

NDA 012945 describes DIAMOX, which is a drug marketed by Teva Branded Pharm and Teva Womens and is included in three NDAs. It is available from two suppliers. Additional details are available on the DIAMOX profile page.

The generic ingredient in DIAMOX is acetazolamide sodium. There are ten drug master file entries for this compound. Four suppliers are listed for this compound. Additional details are available on the acetazolamide sodium profile page.

Summary for 012945

Tradename:1
Applicant:1
Ingredient:1
Patents:0
Therapeutic Class:Ophthalmic Agents
Formulation / Manufacturing:see details

Pharmacology for NDA: 012945

Ingredient-typeSulfonamides
Mechanism of ActionCarbonic Anhydrase Inhibitors

Suppliers and Packaging for NDA: 012945

Tradename Generic Name Dosage NDA Application Type Supplier National Drug Code Package Code Package
DIAMOX acetazolamide CAPSULE, EXTENDED RELEASE;ORAL 012945 NDA AUTHORIZED GENERIC Barr Laboratories Inc. 0555-0513 0555-0513-02 100 CAPSULE, EXTENDED RELEASE in 1 BOTTLE (0555-0513-02)
DIAMOX acetazolamide CAPSULE, EXTENDED RELEASE;ORAL 012945 NDA Teva Women's Health, Inc. 51285-754 51285-754-02 100 CAPSULE, EXTENDED RELEASE in 1 BOTTLE (51285-754-02)

Summary for product number 001

Active Rx/OTC/Discontinued:RXDosage:CAPSULE, EXTENDED RELEASE;ORALStrength500MG
Approval Date:Approved Prior to Jan 1, 1982TE:ABRLD:Yes


Complete Access Available with Subscription
« Back to Dashboard

For more information try a trial or see the plans and pricing

Serving leading biopharmaceutical companies globally:

Colorcon
Accenture
Daiichi Sankyo
Merck
US Department of Justice
Teva
Farmers Insurance
US Army
Mallinckrodt
Fuji

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:

botpot